Evidence map›Paper›PMID 32059753›Full record

ArticleOncology research2020

miRNA-mRNA Profiling Reveals Prognostic Impact of

Nikhil Gadewal, Rohit Kumar, Swapnil Aher, Anagha Gardane, Tarang Gaur, Ashok K Varma, Navin Khattry, Syed K Hasan

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. BiallelicEJHaem · 2023
    Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nikhil GadewalBioinformatics Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)Navi MumbaiIndia.
Rohit KumarCell and Tumor Biology Group, Advanced Centre for Treatment, Research and Education in CancerNavi MumbaiIndia.
Swapnil AherCell and Tumor Biology Group, Advanced Centre for Treatment, Research and Education in CancerNavi MumbaiIndia.
Anagha GardaneCell and Tumor Biology Group, Advanced Centre for Treatment, Research and Education in CancerNavi MumbaiIndia.
Tarang GaurCell and Tumor Biology Group, Advanced Centre for Treatment, Research and Education in CancerNavi MumbaiIndia.
Ashok K VarmaBioinformatics Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)Navi MumbaiIndia.
Navin KhattryAdult Hemato-lymphoid Disease Management Group, Tata Memorial HospitalMumbaiIndia.
Syed K HasanCell and Tumor Biology Group, Advanced Centre for Treatment, Research and Education in CancerNavi MumbaiIndia.
Advanced Centre for Treatment, Research and Education in Cancer · INTata Memorial Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute myeloid leukemia (AML) with

Indexed as

Gene Expression Regulation, LeukemicRNA InterferenceCell Cycle ProteinsChromosomal Proteins, Non-HistoneComputational BiologyFemaleGene Expression ProfilingHigh-Throughput Nucleotide SequencingHumansLeukemia, Myeloid, AcuteMaleMicroRNAsMutationNucleophosminPrognosisRNA, MessengerCell Cycle ProteinsChromosomal Proteins, Non-HistoneMicroRNAsNPM1 protein, humanNucleophosminRNA, MessengerStructural Maintenance of Chromosome Protein 1

Identifiers

PMID32059753
PMCPMC7851519
OpenAlexW3006078752

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.